Cargando…

Preferential translation of p53 target genes

The transcription factor p53 exerts its tumour suppressive effect through transcriptional activation of numerous target genes controlling cell cycle arrest, apoptosis, cellular senescence and DNA repair. In addition, there is evidence that p53 influences the translation of specific mRNAs, including...

Descripción completa

Detalles Bibliográficos
Autores principales: Hisaoka, Miharu, Schott, Johanna, Bortecen, Toman, Lindner, Doris, Krijgsveld, Jeroen, Stoecklin, Georg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993080/
https://www.ncbi.nlm.nih.gov/pubmed/35388737
http://dx.doi.org/10.1080/15476286.2022.2048562
_version_ 1784683840228294656
author Hisaoka, Miharu
Schott, Johanna
Bortecen, Toman
Lindner, Doris
Krijgsveld, Jeroen
Stoecklin, Georg
author_facet Hisaoka, Miharu
Schott, Johanna
Bortecen, Toman
Lindner, Doris
Krijgsveld, Jeroen
Stoecklin, Georg
author_sort Hisaoka, Miharu
collection PubMed
description The transcription factor p53 exerts its tumour suppressive effect through transcriptional activation of numerous target genes controlling cell cycle arrest, apoptosis, cellular senescence and DNA repair. In addition, there is evidence that p53 influences the translation of specific mRNAs, including translational inhibition of ribosomal protein synthesis and translational activation of MDM2. A challenge in the analysis of translational control is that changes in mRNA abundance exert a kinetic (passive) effect on ribosome densities. In order to separate these passive effects from active regulation of translation efficiency in response to p53 activation, we conducted a comprehensive analysis of translational regulation by comparative analysis of mRNA levels and ribosome densities upon DNA damage induced by neocarzinostatin in wild-type and TP53(−/−) HCT116 colorectal carcinoma cells. Thereby, we identified a specific group of mRNAs that are preferentially translated in response to p53 activation, many of which correspond to p53 target genes including MDM2, SESN1 and CDKN1A. By subsequent polysome profile analysis of SESN1 and CDKN1A mRNA, we could demonstrate that p53-dependent translational activation relies on a combination of inducing the expression of translationally advantageous isoforms and trans-acting mechanisms that further enhance the translation of these mRNAs.
format Online
Article
Text
id pubmed-8993080
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-89930802022-04-09 Preferential translation of p53 target genes Hisaoka, Miharu Schott, Johanna Bortecen, Toman Lindner, Doris Krijgsveld, Jeroen Stoecklin, Georg RNA Biol Research Paper The transcription factor p53 exerts its tumour suppressive effect through transcriptional activation of numerous target genes controlling cell cycle arrest, apoptosis, cellular senescence and DNA repair. In addition, there is evidence that p53 influences the translation of specific mRNAs, including translational inhibition of ribosomal protein synthesis and translational activation of MDM2. A challenge in the analysis of translational control is that changes in mRNA abundance exert a kinetic (passive) effect on ribosome densities. In order to separate these passive effects from active regulation of translation efficiency in response to p53 activation, we conducted a comprehensive analysis of translational regulation by comparative analysis of mRNA levels and ribosome densities upon DNA damage induced by neocarzinostatin in wild-type and TP53(−/−) HCT116 colorectal carcinoma cells. Thereby, we identified a specific group of mRNAs that are preferentially translated in response to p53 activation, many of which correspond to p53 target genes including MDM2, SESN1 and CDKN1A. By subsequent polysome profile analysis of SESN1 and CDKN1A mRNA, we could demonstrate that p53-dependent translational activation relies on a combination of inducing the expression of translationally advantageous isoforms and trans-acting mechanisms that further enhance the translation of these mRNAs. Taylor & Francis 2022-04-07 /pmc/articles/PMC8993080/ /pubmed/35388737 http://dx.doi.org/10.1080/15476286.2022.2048562 Text en © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Paper
Hisaoka, Miharu
Schott, Johanna
Bortecen, Toman
Lindner, Doris
Krijgsveld, Jeroen
Stoecklin, Georg
Preferential translation of p53 target genes
title Preferential translation of p53 target genes
title_full Preferential translation of p53 target genes
title_fullStr Preferential translation of p53 target genes
title_full_unstemmed Preferential translation of p53 target genes
title_short Preferential translation of p53 target genes
title_sort preferential translation of p53 target genes
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993080/
https://www.ncbi.nlm.nih.gov/pubmed/35388737
http://dx.doi.org/10.1080/15476286.2022.2048562
work_keys_str_mv AT hisaokamiharu preferentialtranslationofp53targetgenes
AT schottjohanna preferentialtranslationofp53targetgenes
AT bortecentoman preferentialtranslationofp53targetgenes
AT lindnerdoris preferentialtranslationofp53targetgenes
AT krijgsveldjeroen preferentialtranslationofp53targetgenes
AT stoecklingeorg preferentialtranslationofp53targetgenes